aztreonam has been researched along with Bone Marrow Diseases in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Bone Marrow Diseases: Diseases involving the BONE MARROW.
Excerpt | Relevance | Reference |
---|---|---|
"Aztreonam is a synthetic, monobactam antibiotic structurally related to the beta-lactam class of drugs." | 5.28 | Aztreonam-induced myelosuppression during treatment of Pseudomonas aeruginosa pneumonia. ( Czachor, JS; Dallal, MM, 1991) |
"Aztreonam is a synthetic, monobactam antibiotic structurally related to the beta-lactam class of drugs." | 1.28 | Aztreonam-induced myelosuppression during treatment of Pseudomonas aeruginosa pneumonia. ( Czachor, JS; Dallal, MM, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dallal, MM | 1 |
Czachor, JS | 1 |
1 other study available for aztreonam and Bone Marrow Diseases
Article | Year |
---|---|
Aztreonam-induced myelosuppression during treatment of Pseudomonas aeruginosa pneumonia.
Topics: Aztreonam; Bone Marrow; Bone Marrow Diseases; Humans; Male; Middle Aged; Pneumonia; Pseudomonas Infe | 1991 |